| Novartis Pharma Schweiz AG - Revolade 12,5 mg, Filmtabletten | | 60122 | | 05 | | Revolade 12,5 mg | | Filmtabletten | | B02BX05 | | Eltrombopag | | 18.09.2017 | | |
| | Composition | | eltrombopagum 12.5 mg ut eltrombopagum olaminum, mannitolum, cellulosum microcristallinum, povidonum K 30, carboxymethylamylum natricum A corresp. natrium 0.392-0.588 mg, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, polysorbatum 80, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Eltrombopagum | 12.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Eltrombopagum | 12.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Mannitol | | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 005 | 14 | 249.49 | 287.75 | A | SL | No |
|
|
